If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 23 Oct: Dedication, not defeat
• 23 Oct: ‘Of all the moments for science to slow down, this is not it.’
• 10 Nov: Vector control has prevented over 1 billion malaria cases in Africa since 2000, new analysis reveals
• 13 Nov: WHO Report Shows TB Gains, But Funding Gaps Threaten Momentum
• 19 Nov: Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
• 18 Aug: Japan commits new funding to develop treatments for drug-resistant infections
• 12 Nov: EuTYPH-C Inj.® Multi-dose demonstrates strong safety and immunogenicity: Results now available from a Phase 3 study
• 14 Nov: Expanding access to malaria vaccines in Africa
• 12 Nov: MMV announced as an Action for Women’s Health awardee
• 12 Nov: Phase 3 trial for next-generation malaria treatment GanLum meets primary endpoint, with potential to combat antimalarial resistance
• 13 Nov: Belém Health Action Plan (BHAP): Joint statement by CEPI, DNDi, MMV, and Unitaid
• 19 Nov: WHO approves first child-friendly primaquine formulations for malaria treatment
• 24 Nov: A race against time: antimalarial drug resistance
• 4 Nov: European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi
• 11 Sep: FIND announces appointment of Dr Jutta Reinhard-Rupp as Chief Scientific Officer
• 13 Nov: International Vaccine Institute Board of Trustees convenes in Rwanda, underscoring deepening commitment to Africa’s vaccine ecosystem and global health collaboration
• 14 Nov: EVI at ASTMH 2025: Advancing maternal health through placental malaria vaccine research
MDGH
PDP Funder News/Announcements
• 13 Nov: Africa leads the way on genetically modified mosquitoes. Unitaid
• 5 Oct: Advancing new and underused innovations to end preventable death in childbirth. Unitaid
• 19 Nov: WHO approves first child-friendly primaquine formulations for malaria treatment. Unitaid
• 24 Nov: Mpox shows why access must be built in from the start. Unitaid
• 25 Nov: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations. EDCTP
• 28 Nov: A golden era of tuberculosis vaccines is coming – but is the world ready?. Wellcome
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 10 Nov: Report: State of disunion: The impact of US funding cuts on global health R&D. Impact for Global Health
• 10 Nov: Pipeline Report: 2025 Tuberculosis Diagnostics. TAG
• 18 Nov: Genetically modified mosquitoes: Technology and access landscape report. Unitaid
• 25 Nov: The 2025 HIV Market Report: The state of the HIV market in low- and middle-income countries. CHAI
• 25 Nov: The changing impact of malaria control in Africa 2000-2025. Malaria Atlas Project
Related Press Releases/ Announcements/Articles
• 1 Nov: A global health expert on Covid’s lessons — and warnings — for the future. STAT
• 2 Oct: WHO releases new reports on new tests and treatments in development for bacterial infections. WHO
• 2 Oct: Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025. WHO
• 2 Oct: Broader access urged for affordable HIV drug. SciDevNet
• 2 Oct: Babies' deaths in Cameroon show how US aid cuts curtail malaria fight. Reuters
• 2 Oct: New study shows all-in-one coronavirus vaccines could save millions of lives in future pandemics. CEPI
• 3 Nov: EIB signs a Guarantee Agreement with MedAccess to boost access to essential medical supplies in Africa. EIB
• 3 Nov: From Warp Speed to COVAX: An insider’s story. Politico
• 3 Nov: WHO issues guidance to address drastic global health financing cuts. WHO
• 3 Nov: Faulty field test undermines fight against malaria, says new research. The Telegraph
• 3 Nov: Trial data highlight sustained protection from dengue vaccine. CIDRAP
• 4 Nov: WHO and Bayer AG renew longstanding collaboration to eliminate three deadly neglected tropical diseases. WHO
• 4 Nov: Global perspectives on infectious diseases at risk of escalation and their drivers. Nature
• 4 Nov: G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults. The Lancet Infectious Diseases
• 4 Nov: Every pound of UK aid put into disease control guards against one of the most dangerous enemies of our time. The Independent
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 4 Nov: In rural Malawi, malaria might have wings but the malaria vaccine rides a bike. Gavi
• 4 Nov: Faulty malaria rapid test raises global concerns, say MORU researchers. Centre for Tropical Medicine & Global Health
• 4 Nov: Countries Criticise ‘Inadequate’ Pathogen-Sharing Draft Annex at Start of Text-Based Talks. Health Policy Watch
• 4 Nov: Smarter Vaccine Doses: A High-Impact Fix for Global Immunization. CGD
• 4 Nov: Withdrawal of US aid has hurt South Africa’s HIV programme. Spotlight
• 5 Nov: America has turned its back on science. Could the UK save the world?. The New World
• 5 Nov: Lenacapavir Regulatory Approval. AVAC
• 5 Nov: Geographical Diversification of Vaccine Production: Challenges for Africa and Latin America. CGD
• 6 Nov: Navigating change to shape the future of global health research. NIHR
• 6 Nov: WHO publishes new global research agenda to strengthen paediatric clinical trials. WHO
• 6 Nov: Untangling choices: how awareness and socio-economic status shape malaria vaccination decisions among Ghanaian women. Malaria Journal
• 6 Nov: New Portable Test Detects Asymptomatic Malaria in 45 Minutes. Medscape
• 6 Nov: Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi. The Lancet
• 6 Nov: WHO voices concerns about equitable access to novel TB vaccines. CIDRAP
• 6 Nov: Biovac opens new vaccine lab in Cape Town to boost Africa's manufacturing capacity. Reuters
• 6 Nov: AI steps in to detect the world's deadliest infectious disease. NPR
• 6 Nov: IAVI’s Lassa fever vaccine shows promise in early clinical trials. CEPI
• 6 Nov: Questions for the America First Global Health Strategy. Think Global Health
• 6 Nov: What the launch of the African Medicines Agency means for drug and health regulation. Nature
• 7 Nov: B cells targeting parasites capture spatially linked antigens to secure T cell help. Science
• 7 Nov: American Barter: Aid In Exchange for Information on Pathogen. Geneva Health Files
• 7 Nov: "Relief" for mothers in Bayelsa state as malaria vaccine makes waves. Gavi
• 7 Nov: ‘Africa could be at a turning point in the fight against malaria’. Channel Africa
• 7 Nov: New study evaluates accuracy of rapid diagnostic tests for malaria. Centre for Tropical Medicine & Global Health
• 7 Nov: 'Needle in a haystack' experiments reveal targets for new tuberculosis vaccines. Fierce Biotech
• 7 Nov: US template for bilateral health deals bypasses WHO pandemic negotiations. Devex
• 7 Nov: MPOX outbreak in Africa: the urgent need for local manufacturing of the vaccine and decolonized health systems. BMC
• 7 Nov: Bilateral deals would undermine pandemic preparedness, multilateralism is the only answer. The Independent Panel
• 7 Nov: State Department Plans New Framework to Advance America First Global Health Strategy. Bloomberg
• 7 Nov: UK set to slash aid funding to fight deadly diseases – putting 250,000 lives at risk. The Independent
• 7 Nov: Africa CDC Pushes for Country-Level Action in Version 2.0 of the African Union Framework for AMR (2026–2030). Africa CDC
• 8 Nov: Budget's $2.7B cut to foreign aid leaves international development in limbo, say NGOs. CBC
• 8 Nov: US to demand countries share data on ‘pathogens with epidemic potential’ in return for health aid. The Guardian
• 8 Oct: The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy. Nature Vaccines
• 8 Oct: Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial. The Lancet HIV
• 8 Oct: Dolutegravir in neonates: finally we are getting there!. The Lancet HIV
• 8 Oct: Stronger, faster, fairer: making mpox vaccines accessible. CEPI
• 8 Oct: Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. NEJM
• 8 Oct: ‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge. The New York Times
• 8 Oct: UK launches new aid inquiry in response to 40% budget cut. Devex
• 9 Oct: Africa must lead its own health research revolution. SciDevNet
• 9 Oct: The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV
• 9 Oct: Elucidated protein structures in the malaria parasite offer opportunities for new vaccines. MedicalXpress
• 9 Oct: Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people. STAT
• 9 Nov: New Tanzanian Malaria vaccine shows strong immune response in early trials. The Citizen
• 9 Nov: Global research partnerships and the impact of inequitable research practices on systematic reviews. BMJ
• 9 Oct: US aid cuts are being felt across Africa. Here’s where.. The Washington Post
• 10 Nov: Maximizing researcher–policymaker engagement in global public health. Nature
• 10 Nov: Africa finally has its own drug-regulation agency — and it could transform the continent’s health. Nature
• 10 Nov: How the mpox vaccine has changed lives – and minds – in Kinshasa. Gavi
• 11 Nov: African Countries Affirm Support for Multilateral Pandemic Agreement Amid Pressure to Make Bilateral Deals with US. Health Policy Watch
• 11 Nov: Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review. BMC
• 11 Nov: In real-world study, malaria vaccine effectiveness matches clinical trials. CIDRAP
• 11 Nov: UK cuts contribution to Aids, tuberculosis and malaria fund by £150m. The Guardian
• 11 Nov: Preparing for LEN: Learning Lessons, Accelerating Access, Reducing Time to Impact. AVAC
• 11 Nov: Equitable access to costly new drugs. BMJ
• 11 Nov: Tuberculosis laboratory capacity building in the WHO African Region: The past, the present and the future: A Viewpoint. PLOS
• 11 Nov: Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements. BMJ
• 12 Nov: Novartis’ new malaria treatment shows promise against resistant parasites. Devex
• 12 Nov: How the Stop TB board plans to future-proof tuberculosis finance. Devex
• 12 Nov: New malaria drug could be a life-saver as the standard drug shows signs of weakness. NPR
• 12 Nov: New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial. Health Policy Watch
• 12 Nov: ‘Music To Our Ears’: A New Malaria Treatment May Offer Long-Awaited Alternative to Artemisinin. Global Health Now
• 12 Nov: Are we getting closer to the world’s first Nipah vaccine?. Gavi
• 12 Nov: As Belgium Races to Save U.S.A.I.D. Contraception, Some Supplies Are Reported Ruined. The New York Times
• 12 Nov: Scientific advances collide with major infrastructure upheaval. AVAC
• 12 Nov: Global gains in tuberculosis response endangered by funding challenges. WHO
• 12 Nov: WHO cites progress against TB globally but warns about reduced funding. CIDRAP
• 12 Nov: South Africa making first new cholera vaccine in decades. The Telegraph
• 13 Nov: New malaria treatment could fight growing threat of drug resistance. EuroNews
• 13 Nov: US has begun bilateral health negotiations with 16 African nations. Devex
• 13 Nov: Prequalifying the Qualified: The Lenacapavir Paradox. IHP
• 13 Nov: AMR is not just a medical crisis: It an ecological and governance crisis. IHP
• 13 Nov: Rift Valley fever vaccine safe, immune-producing in adults, early-stage trial shows. CIDRAP
• 13 Nov: Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings. Fierce Pharma
• 13 Nov: Weathering the Donor Downturn: The Case for a New Financial Model for the Global Fund. CGD
• 13 Nov: COP30 report reveals how climate change is spreading infectious diseases to new regions. The Conversation
• 13 Nov: AI to tailor malaria and TB drugs to Africa; fungus that lures mosquitoes; and how to address nutrition deficits on the continent. Nature
• 14 Nov: Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study. The Lancet HIV
• 14 Nov: Single-dose malaria treatment as effective as multi-dose regimen, trial shows. CIDRAP
• 14 Nov: Denmark to cut IAVI funds, prioritizing multilaterals over smaller grants. Devex
• 14 Nov: Collaborating for greater impact — Rwanda’s fight against AMR. Devex
• 14 Oct: Novo Nordisk Foundation pledges up to $31M to support AI-powered pandemic preparedness platform. Fierce Biotech
• 14 Oct: Report proposes new framework to prepare for future pandemics. CIDRAP
• 14 Oct: POST introduction evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021. Malaria Journal
• 14 Oct: Africa imports over 70% of its medicines. Making active ingredients locally would change this. Gavi
• 14 Oct: Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1. CEPI
• 14 Oct: Stop playing catch-up with superbugs: the anticipatory governance of antimicrobial resistance. WEF
• 15 Nov: What it takes to build vaccine manufacturing capacity in emerging markets. The New Times
• 15 Nov: Ethiopia confirms outbreak of deadly Marburg virus. The Guardian
• 15 Nov: Closing the deal: a G20 panel report on financing for pandemic threats. The Lancet
• 15 Nov: Value profile for Malaria vaccines and monoclonal antibodies. Science
• 17 Nov: Many poor countries where experimental drugs are tested fail to benefit after approval, analysis finds. STAT
• 17 Nov: World AMR Awareness Week 2025 urges action to turn political commitments into life-saving interventions. WHO
• 17 Nov: African Diplomats Reaffirm Africa’s Unwavering Commitment to Global Health and Support to the Global Fund’s Replenishment. The Global Fund
• 17 Nov: Lenacapavir Plus Broadly Neutralizing Antibodies Maintains Viral Suppression. POZ
• 17 Nov: Malaria: Organic larvicide may achieve breakthrough. Daily Monitor
• 17 Nov: Trump slashed spending on clinical trials. The toll is starting to become clear. The Washington Post
• 17 Nov: Antibody responses to polymorphic Plasmodium falciparum merozoite antigens in Malawian children with severe and uncomplicated malaria. Malaria Journal
• 17 Nov: Exploring New Frontiers in the Fight Against Malaria. Health Policy Watch
• 17 Nov: Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals. JAMA
• 18 Nov: First doses of HIV prevention drug lenacapavir delivered to Zambia, Eswatini. Reuters
• 18 Nov: New online hub for antimicrobial resistance data launches. CIDRAP
• 18 Nov: Staying the course amid change: Reflections on a season of global health engagement. GHTC
• 18 Nov: GSK and Fleming Initiative scientists unite to target AMR with advanced AI. GSK
• 18 Nov: Researchers call on UK to step up support for antimicrobial discovery and development. IDS
• 18 Nov: Awareness, acceptability, and willingness to pay for the R21/Matrix-M malaria vaccine: a cross-sectional study among pregnant women and nursing mothers in Enugu State, Nigeria. BMC Public Health
• 18 Nov: Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP’s qualitative evidence. Malaria Journal
• 18 Nov: mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model. Nature
• 18 Nov: Innovation meets impact: Fighting malaria in a warming world. Devex
• 18 Nov: EXCLUSIVE: WHO Cutting Up to 25% of Staff by June 2026 – But ‘Shadow Workforce of Consultants’ Is Unreported. Health Policy Watch
• 18 Nov: The Malaria Vaccine Brings New Hope to Children and Caregivers in Zambia. Unicef
• 18 Nov: Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa. STAT
• 18 Nov: A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout. NPR
• 18 Nov: Trump Takes Credit for Lenacapavir Deal after His Administration Decimated U.S. International AIDS Prevention Programs. Public Citizen
• 18 Nov: US health strategy aims to position African governments as customers. Devex
• 18 Nov: How One Vaccine Could Help Fight Drug-Resistant Infections. Foreign Policy
• 19 Nov: Modelling the impact of different intervention packages for malaria control under varying intensities of pyrethroid resistance. Malaria Journal
• 19 Nov: Private Sector Mobilize Innovation for Health Equity and Resilience at B20 Global Health Breakout. The Global Fund
• 19 Nov: The Netherlands Reaffirms Commitment to Global Health. The Global Fund
• 19 Nov: More countries report rising levels of drug-resistant gonorrhoea, warns WHO. WHO
• 19 Nov: Global south's TB diagnostics innovations are key to fight the epidemic. Devex
• 19 Nov: As novel approaches drive TB testing expansion, global goal of disease eradication remains elusive. 360Dx
• 19 Nov: The future of global health is at stake. These 7 pioneers could revolutionize it. Vox
• 19 Nov: Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages. News Medical
• 19 Nov: New drug could be a breakthrough in treatment for killer TB, trial suggests. The Guardian
• 20 Nov: AI and citizens detect invasive mosquito in Madagascar. Gavi
• 20 Nov: Neglecting infectious diseases is a market failure. Financial Times
• 20 Nov: SA Calls for Unified African Action to Build Sustainable Vaccine Manufacturing. DeviDiscourse
• 20 Nov: Ethiopia battles first-ever Marburg outbreak. Gavi
• 20 Nov: A blueprint for access at the heart of outbreak R&D. CEPI
• 20 Nov: UK initiative to explore using AI to address antimicrobial resistance. CIDRAP
• 20 Nov: “We need to be intentional”: five voices on disability inclusive health research in Uganda. The London School of Tropical Medicine and Hygiene
• 20 Nov: South Africa is urged by advocates to issue a compulsory license for Gilead’s HIV prevention drug. STAT
• 20 Nov: Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk. Health Policy Watch
• 20 Nov: Fundraising summit for Aids, TB and malaria expected to fall billions of pounds short. The Telegraph
• 21 Nov: Beyond the Breakthrough: The Uneven Geography of mRNA Vaccine Production. Geneva Health Files
• 21 Nov: Common bacterial infections becoming increasingly untreatable, WHO warns. Gavi
• 21 Nov: Global Fund raised $11.34 billion with a surprising US pledge. Devex
• 21 Nov: First look: Full Text of America First Global Health Strategy Specimen Sharing Agreement. Emily Bass
• 21 Nov: First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharan Africa – and What it Means for Ending the HIV Epidemic. Gilead
• 21 Nov: Evolving the global HIV/AIDS response: Emerging tools and new opportunities. GHTC
• 21 Nov: Exclusive: CDC to end all monkey research. Science
• 21 Nov: Africa CDC Launches AGARI, a Continent-Wide Genomic Data Platform to Strengthen Outbreak Response. Africa CDC
• 21 Nov: Africa CDC Unveils a New Vision for Health Security and Sovereignty Across the Continent. Africa CDC
• 22 Nov: The European Investment Bank's focus on health. The Lancet
• 22 Nov: Africa's Health Security and Sovereignty agenda: a new way forward. The Lancet
• 22 Nov: Control of HIV, TB and malaria at risk after global health fund donations fall. The Guardian
• 23 Oct: Can Africa’s drug regulators be both fast and trusted?. Devex
• 23 Oct: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. Science Direct
• 23 Oct: Inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials: health, ethical, and regulatory considerations. The Lancet
• 23 Nov: Malaria vaccine price cut set to protect 7 million more children by 2030. UN News
• 24 Nov: Gavi and UNICEF announce equitable pricing deal for malaria vaccine to protect 7 million more children by end of decade. Gavi
• 24 Nov: Investing in opportunity: How venture capital powers social impact. Devex
• 24 Nov: UNICEF, Gavi deal slashes malaria vaccine price to $2.99 per dose. Devex
• 24 Nov: Strengthening global preparedness and response to arboviral disease threats: a call to action. The Lancet
• 24 Nov: GSK and ISGlobal Sign Framework Agreement to Advance Global Health Research. IS Global
• 24 Nov: Fightback: scientists score series of wins in battle against superbugs. The Telegraph
• 24 Nov: Marburg outbreak worsens in Ethiopia as death toll rises. The Telegraph
• 24 Nov: HIV Prevention R&D at Risk. AVAC
• 24 Nov: To tackle rising antibiotic resistance, GARDP aims for access. CIDRAP
• 24 Nov: New vapor tool fights mosquitoes by slowly releasing insecticide in homes. Will it catch on?. Science
• 24 Nov: "The biggest tech transfer program in the history of all medical technology": Petro Terblanche, CEO, Afrigen Biologics And Vaccines on the mRNA Tech Transfer Programme . Geneva Health Files
• 25 Nov: EDCTP: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations. Science Business
• 25 Nov: New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments. CIDRAP
• 25 Nov: Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis. The Guardian
• 26 Nov: New vaccines could help us consign tuberculosis to history: here’s how we can do it. Gavi
• 26 Nov: Some high-flying tropical mosquitoes carry disease-causing pathogens long distances, study finds. CIDRAP
• 26 Nov: A Turning Point: Lusaka Agenda is Anchored in the G20 Declaration. Health Policy Watch
• 26 Nov: Can AI Democratize the Global Fight Against Malaria?. Health Policy Watch
• 26 Nov: A much-needed vaccine for Nipah virus. Nature
• 27 Nov: Breakthrough in Malaria Prevention: New Vaccine and Adjuvant Unveiled. Devidiscourse
• 27 Nov: “Miraculous” HIV drug to be rolled out after overcoming aid cuts threat. BMJ
• 27 Nov: Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in global health. The Korea Herald
• 27 Nov: “Act Now!” Yes, but with what, exactly? On #AMR and the realities of unequal access. IHP
• 27 Nov: What will the Global Development Architecture look like in 2030? And What can the EU and UK do to Influence It?. Global Policy Journal
• 27 Nov: Beyond resistance: alternative innovation models for global access and stewardship of new antibiotics. Nature
• 28 Oct: WHO Member States Get Skeleton Draft on Pathogen Sharing Ahead of Text-Based Negotiations. Health Policy Watch
• 28 Oct: Transforming HIV Prevention in 2025. AVAC
• 29 Nov: Amid massive cuts, Global Fund raises $11 billion. The Lancet
• 29 Nov: The Global Fund and the future of global health. The Lancet
• 29 Oct: ‘The Great Mimicker’: meet the deadly bacterium spreading worldwide. Gavi
• 29 Oct: Possible EU cuts to HIV and vaccine funding ‘irresponsible’, Global Fund says. Euractiv
• 29 Oct: Global vaccine safety network to launch in six countries across three continents. CEPI
• 29 Nov: The New U.S. Global Health Strategy — A Reset of America’s Health Cooperation. NEJM
• 30 Oct: Innovations in Sexual and Reproductive Health. The Lancet
• 30 Oct: Access Strategy for Lenacapavir for PrEP in Low- and Middle-Income Countries. Gilead
• 30 Oct: How Moderna, the company that helped save the world, unraveled. STAT
• 31 Oct: Working to Make Africa Attractive for Global Clinical Trials. Health Policy Watch
Upcoming Meetings/ Webinars
--------------------------